A vaccine that can prevent more than 90 per cent of people from getting Covid-19 could mean the return of in-person conferences and events sooner than most people had anticipated. Early analysis shows the jab – developed by Pfizer and BioNTech – is effective and safe, and the companies plan to apply for emergency approval to use the...